Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Dicker

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Cancer Research|January 14, 2016
Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 ActivationVarun V Prabhu, Bo Hong, Joshua E Allen, et al.
Cancer Biology & Therapy|October 26, 2021
Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer <i>in vitro</i> and <i>in vivo</i>Jocelyn E Ray, Marie D Ralff, Aakash Jhaveri, et al.
Cell Cycle (Georgetown, Tex.)|July 2, 2011
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumabLori S Hart, Nathan G Dolloff, David T Dicker, et al.
Cancer Biology & Therapy|November 20, 2009
The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cellsCatherine Huang, Xiang M Zhang, Raluca T Tavaluc, et al.
Cancer Research|October 25, 2017
miR-6883 Family miRNAs Target CDK4/6 to Induce G<sub>1</sub> Phase Cell-Cycle Arrest in Colon Cancer CellsAmriti R Lulla, Michael J Slifker, Yan Zhou, et al.
Molecular Cancer Research : MCR|March 29, 2018
ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate CancerAvital Lev, Amriti R Lulla, Brian C Ross, et al.
Cancer Biology & Therapy|December 30, 2009
Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesotheliomaSharyn I Katz, Lanlan Zhou, Grace Chao, et al.
Cancer Biology & Therapy|December 25, 2008
TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell deathKageaki Kuribayashi, Gabriel Krigsfeld, Wenge Wang, et al.
Plos One|April 5, 2013
The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancerJoshua E Allen, Jean-Nicolas Gallant, David T Dicker, et al.
Molecular Cancer Therapeutics|September 12, 2012
Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9Nathan G Dolloff, Joshua E Allen, David T Dicker, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Cancer Research|January 14, 2016
Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 ActivationVarun V Prabhu, Bo Hong, Joshua E Allen, et al.
Cancer Biology & Therapy|October 26, 2021
Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer <i>in vitro</i> and <i>in vivo</i>Jocelyn E Ray, Marie D Ralff, Aakash Jhaveri, et al.
Cell Cycle (Georgetown, Tex.)|July 2, 2011
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumabLori S Hart, Nathan G Dolloff, David T Dicker, et al.
Cancer Biology & Therapy|November 20, 2009
The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cellsCatherine Huang, Xiang M Zhang, Raluca T Tavaluc, et al.
Cancer Research|October 25, 2017
miR-6883 Family miRNAs Target CDK4/6 to Induce G<sub>1</sub> Phase Cell-Cycle Arrest in Colon Cancer CellsAmriti R Lulla, Michael J Slifker, Yan Zhou, et al.
Molecular Cancer Research : MCR|March 29, 2018
ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate CancerAvital Lev, Amriti R Lulla, Brian C Ross, et al.
Cancer Biology & Therapy|December 30, 2009
Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesotheliomaSharyn I Katz, Lanlan Zhou, Grace Chao, et al.
Cancer Biology & Therapy|December 25, 2008
TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell deathKageaki Kuribayashi, Gabriel Krigsfeld, Wenge Wang, et al.
Plos One|April 5, 2013
The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancerJoshua E Allen, Jean-Nicolas Gallant, David T Dicker, et al.
Molecular Cancer Therapeutics|September 12, 2012
Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9Nathan G Dolloff, Joshua E Allen, David T Dicker, et al.
Pageof 10